Peak amplitude recovery exhibited a highly significant positive correlation with increasing IBIs in all regions examined, including CA1-SR ( Figure 5D , p < 0.0001), CA2-SR ( Figure 5F , p < 0.0001), and CA1-SLM ( Figure 5H , p < 0.0001).
Excerpts
The t-value from the student's paired t-test was 19, indicating a moderately significant difference (p = 0.0001, S).
25 Furthermore, during milk OIT, the risk of reactions and the need for epinephrine treatment was highly significant ( p < 0.0001). 25 These patients were also at a higher risk of OIT discontinuation or not achieving full desensitization.
Generally, P > 0.05 was considered statistically insignificant (ns), P < 0.01 was considered significant (**), P < 0.001 was considered highly significant (***), and P < 0.0001 was considered very highly significant (****).
This difference was highly significant ( P < 0.0001).
When assessing the inter-assay correlation between IFA and PRNT50, we observed a highly significant correlation (Spearman r value: 0.57; p < 0.0001; Figure 1 C).
The model F-values were found to be highly significant for both responses (vesicle size and entrapment efficiency), with p-values < 0.0001 for vesicle size and 0.0014 for entrapment efficiency.
The correlation between vascularization and the Breslow thickness was highly significant ( p <0.0001).
total and stage I+II ovarian cancer is highly significant (P<0.0001) but negligible for healthy vs. stages III+IV cancer (P = 0.043); in contrast for the more important differentiation between benign vs. ovarian cancer, the difference between CA125 and the panel is missing for benign vs. total and stage I+II ovarian cancer and rather better for benign vs. stage III+IV ovarian cancer (P = 0.045).
Despite the different set of antibodies employed and potential batch effects, we observed a highly significant correlation between results obtained with the two methodologies (p < 0.0001, r 2 = 0.3).
The difference between the length of outgrowths between the two cell types was determined to be highly significant (P < 0.0001).
The association is strong (ODDS ratio 5.30) and statistically highly significant ( P = 0.0001).
Enrichment analysis of these null variants in heterozygosity against gnomAD-NFE revealed a marginally significant enrichment (OR, 2.39 [95% CI, 1.65–3.47], P <0.0001) that was not validated against internal controls (OR 1.34 95% CI, 0.74–2.42], P =0.337; Table S9 ), reinforcing our approach of treating cases with heterozygous null variants in TRIM63 as negative.
There was a strong trend to reduction of initial ICS prescribing over time, falling from 77% in 2005 to 47% at the end of the study ( p < 0.0001).
We noted a highly significant decrease of circulating plasmablasts ( p < 0.0001), less significant decrease of transitional B cells ( p = 0.029), and a slight but insignificant expansion of naïve B cells in MIS-C patients (Fig. 2 A, B).
Specifically, there was no difference in medial, center, or lateral estimates, but total combined regions showed a highly significant ( p < 0.0001) increase in OLs in Fmr1 KO animals compared to B6.
A highly significant correlation was found between maximal strength in vertebral bodies and BMD measured either by DXA (r = 0.86) or pQCT (r = 0.85) (both p < 0.0001).
The overlap of essential gene predictions and experimental results was highly significant ( P < 0.0001, odds ratio = 2.63).
The association of duration of use remained highly significant for moderate or greater AR ( p < 0.0001) but the association with moderate or greater MR did not reach statistical significance ( p = 0.09, one-sided) while the trend for moderate or greater TR remained statistically significant ( p = 0.007, one-sided).
For the SIADH/cancer subgroup, subjects on tolvaptan exhibited a highly significant improvement in this parameter ( P < 0.0001) relative to placebo to day 4 (5.0 vs. −0.3 mEq/mL) and to day 30 (6.9 vs. 1.0 mEq/L) (Fig. 2 ).
There was a significant heterogeneity among studies I 2 = 88.7% (95% CI: 76.3–94.6%), τ 2 = 17.32, and a highly significant Q -test ( p < 0.0001) ( 14 , 17–20 ).
The miro1 (+/−) / miro2-2 (−/−) plants showed highly significant (P<0.0001) additional impairment of pollen tube growth compared to the miro1 (+/−) alone ( Figure 6 ).
The repeated‐measures ANOVA revealed a highly significant difference among total, dominant, and nondominant mBF (F(2,334) = 136.30, p < 0.0001).
However, intragroup comparison for hardness values showed a statistically highly significant difference for Group 1 ( P < 0.0001) and a nonsignificant difference ( P = 0.4831) for Group 2.
When performing a simple linear regression analysis of all PSA and CA19‐9 serum samples, it revealed a highly significant association ( R 2 = 0.938, p < 0.0001; Figure 3B ).